Monash IVF Group is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Monash IVF Group has a trailing 12-month revenue of around $236 million. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Monash IVF Group, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $1.0382 - $1.5 |
|---|---|
| 50-day moving average | $1.4481 |
| 200-day moving average | $1.321 |
| Target price | $1.52 |
| PE ratio | 24.0333 |
| Dividend yield | $0.045 (3.47%) |
| Earnings per share (TTM) | $0.06 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.49
| 1 week (2024-04-15) | 3.47% |
|---|---|
| 1 month (2024-03-22) | 4.20% |
| 3 months (2024-01-23) | 9.96% |
| 6 months (2023-10-23) | 17.32% |
| 1 year (2023-04-21) | 36.70% |
|---|---|
| 2 years (2022-04-22) | 20.65% |
| 3 years (2021-04-23) | 67.42% |
| 5 years (2019-04-23) | 41.23% |
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Monash IVF Group shares trade at around 24x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $46 million (£24 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $236 million |
|---|---|
| Operating margin TTM | 16.13% |
| Gross profit TTM | $72.8 million |
| Return on assets TTM | 5.74% |
| Return on equity TTM | 8.68% |
| Profit margin | 10.16% |
| Book value | 0.709 |
| Market capitalisation | $561.9 million |
TTM: trailing 12 months
Dividend payout ratio: 70.97% of net profits
Recently Monash IVF Group has paid out, on average, around 70.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.47% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 3.47% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.045 per share.
Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 6 March 2024 (the "ex-dividend date").
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $1.0382 up to $1.5. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.455. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.
AMP Ltd Preferred
AUD104.71
ANZ Group Holdings Ltd. Pfd.
AUD101.63
Challenger Ltd Preferred
AUD105.21
Macquarie Group Ltd Pref C
AUD102.95
Macquarie Group Ltd Pref
AUD105.80
Macquarie Group Preferred
AUD102.91
Macquarie Group Limited
AUD105.97
Suncorp Group Ltd Pref
AUD100.76
Westpac Banking Corp Pref
AUD103.01
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Blinklab shares.
Everything we know about the Maverick Minerals IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a flat $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?